Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing v3.5.4, indicating a newer build. This is a routine maintenance update and does not affect the clinical trial details or how the page is used.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a version bump for the page. This appears to be a minor, metadata-level update rather than a substantive change to study details.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page’s location text for the Chile site has been updated to use a shorter “Valparaiso” label instead of “Región de Valparaíso.” The displayed site revision/version string was also bumped from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check55 days agoChange DetectedUpdated the collaborator name from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and revised the page version from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a citation: Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma (N Engl J Med, 2021). Deleted the Erratum entry for that publication.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.